Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/2005
10/12/2005CN1222509C Prostaglandin derives.
10/12/2005CN1222315C Stable liquid interferon formulations
10/12/2005CN1222295C Neutrophil leucocyte functional inhibitor
10/12/2005CN1222294C Combined preparations comprising morpholine anthracyclines and anticancer agent
10/12/2005CN1222290C Novel composition and use thereof
10/12/2005CN1222288C Use of 3-substituted oxindole derivatives as KCNQ potassium channel modulators
10/12/2005CN1222286C Methods of use for peroxynitrite decompositionc atalysts, pharmaceutical compositions therefor
10/12/2005CN1222284C High lipid diet
10/12/2005CN1222283C Methods of rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction
10/11/2005US6953858 A phenylalkyl secondary- and tertiary-amides enzyme inhibitors as viricides, for treating AIDS
10/11/2005US6953857 Oxybenzamide derivatives useful for inhibiting factor Xa or viia
10/11/2005US6953854 Process for preparing crystalline Form I of cabergoline
10/11/2005US6953853 Phospholipase inhbitors; antiinflammatory agents; respiratory system disorders
10/11/2005US6953838 Urocortin-III and uses thereof
10/11/2005US6953809 Monocyte chemoattractant protein-1 inhibitor compounds
10/11/2005US6953806 Cyclohexane derivatives containing amine or amine oxide, useful for treating hypercholesterolemia and hyperlipemia
10/11/2005US6953804 alkenyl ether functionality at 1-position; immunomodulators that induce cytokine biosynthesis; 1-[2-(2-Propynyloxy)ethyl]-1H-imidazo[4,5-c]quinolin-4-amine;
10/11/2005US6953803 Pyrimidine compounds
10/11/2005US6953801 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
10/11/2005US6953800 Quinazoline derivatives
10/11/2005US6953797 Nitric oxide synthase inhibitor; antiinflammatory agents
10/11/2005US6953796 Use of 2-amino-thiazoline derivatives as inhibitors of inducible No-synthase
10/11/2005US6953795 N-[5-[[3[-(morpholin-4-yl)carbonyl]phenyl]thio]thiazol-2-yl]-4-(N,N-dimethylamino)benzamide; may be combined with antiinflammatory, antiarthritic, antiproliferative, anticancer, anti-cytotoxic or antiallergenic agents
10/11/2005US6953793 For therapy of autoimmune diseases mediated by cathepsin S; for inhibiting the progression of tissue transplant rejection
10/11/2005US6953792 Cyclohexyl derivatives and their use as therapeutic agents
10/11/2005US6953791 Dipeptide derivatives
10/11/2005US6953787 5HT2C receptor modulators
10/11/2005US6953785 Estra-1,3,5(10)-triene derivatives
10/11/2005US6953581 Porcine circovirus and parvovirus vaccine
10/11/2005US6953568 Administering biological conjugates that bind preferentially to endothelial protein C receptor(EPCR), to endothelial cells of vascular systems; genetic translocation; drug delivery
10/11/2005CA2341949C Novel compounds for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses
10/11/2005CA2282277C Atropisomers of 3-aryl-4(3h)-quinazolinones and their use as ampa-receptor antagonists
10/06/2005WO2005093082A1 Method of screening compound capable of accelerating or inhibiting apoptosis, apoptosis accelerator and apoptosis inhibitor
10/06/2005WO2005093068A1 Novel protein and promoter
10/06/2005WO2005093066A1 Marker gene for arthrorheumatism test
10/06/2005WO2005093057A1 Truncated dance, dance complex and method of using these
10/06/2005WO2005092383A1 Preventive/remedy for respiratory diseases
10/06/2005WO2005092367A1 Composition for promoting adiponectin secretion
10/06/2005WO2005092357A1 Antiallergic agent and antiinflammatory agent
10/06/2005WO2005092348A1 Hgf production accelerator containing heparin-like oligosaccharide
10/06/2005WO2005092328A1 Fxr activation compound
10/06/2005WO2005092322A1 Natural compound causing rar activation
10/06/2005WO2005092320A1 Cytoprotective composition
10/06/2005WO2005092069A2 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof
10/06/2005WO2005063294A8 Inhibitor for the formation of ϝ-secretase complex
10/06/2005US20050222424 Phenyloxyalkanonic acid derivatives as hppar activators
10/06/2005US20050222423 Carboxylic acid derivative
10/06/2005US20050222418 Novel tyloindicines and related processes, pharmaceutical compositions and methods
10/06/2005US20050222414 N-(4-methylphenyl)-4-[4-[[(phenylmethoxy)amino]carbonyl]phenyl]-1-piperazinecarboxamide; anticarcinogenic, antiproliferative agent; ovarian carcinoma, psoriasis; gene transcription control
10/06/2005US20050222410 Inhibitors of histone deacetylase
10/06/2005US20050222406 Condensed palatinose in hydrogenated form
10/06/2005US20050222395 New peptide derivatives
10/06/2005US20050222384 Useful as prophylactic and therapeutic agent of dysfunction of masticatory, dysphagia, dysgeusia, ozostomia, intra-oral cavity dysphoria, intra-oral cavity infections, intra-oral cavity inflammations, dry eye, ectocornea detachment, keratitis, corneal ulcer, conjunctivitis, stomach and duodenal ulcers
10/06/2005US20050222273 Treatment of female sexual dysfunction
10/06/2005US20050222268 Administering a compound for inhibiting cation exchange as hypotensive agents
10/06/2005US20050222260 (2S)-2-amino-a-{[2-(ethanimidoylamino) ethyl]thio}butanoic acid, a nitric oxide synthase inhibitor, in stabilized pharmaceutical dosage forms
10/06/2005US20050222259 Methods of activating PPAR-alpha nuclear receptors in mammals
10/06/2005US20050222253 Anti-cancer nitro- and thia-fatty acids
10/06/2005US20050222250 Curcumin for the prevention and/or treatment of tissue damage
10/06/2005US20050222244 Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors
10/06/2005US20050222243 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
10/06/2005US20050222237 Inhibitors of glycogen synthase kinase-3 (GSK-3), a serine/threonine protein kinase; for treatment and prevention of diabetes and Alzheimer's disease
10/06/2005US20050222235 Drugs for improving the prognosis of brain injury and a method of screening the same
10/06/2005US20050222230 3,4-diarylpyrazoles and their use in the therapy of cancer
10/06/2005US20050222224 p53 Inhibitors and therapeutic use of the same
10/06/2005US20050222221 Cell differentiation, regeneration of pancreas epithelial cells to insulin producing beta cells; administering a dipeptidyl-peptidase activators
10/06/2005US20050222217 Agonists and antagonists of nicotinergic acetylcholine receptors of insects like fleas, lice and flies, on humans or animals; chloronicotinyl insecticides such as imidaclopridas veterinary medicine; collars; tags
10/06/2005US20050222216 Carboxyoic acid compounds and drugs containing the compounds as the active ingredient
10/06/2005US20050222215 Broadspectrum heterocyclic substituted phenyl containing sulfonamide hiv protease inhibitors
10/06/2005US20050222214 Administering conjugate having a polyethylene glycol (PEG) moiety covalently bound to the serine residue of antide for therapy of hormonal dependent cancer, endometriosis, uterine fibroids, uterine myoma, and leutinizing hormone (LH) surge in woman undergoing in vitro fertilization
10/06/2005US20050222210 Prodrugs of imidazole derivatives, for use as proton pump inhibitors in the treatment of e.g. peptic ulcers
10/06/2005US20050222206 Pyridinoylpiperidines as 5-ht1f agonists
10/06/2005US20050222201 such as 3-(2-chloro-4-quinolinyl)-2,5-dimethyl-1H-indole-1-acetic acid, used for treating respiratory system disorders and as inhibitors of G protein-coupled receptor chemoattractant homologous receptor expressed on lymphocyte cells (CRTH2)
10/06/2005US20050222199 Process for the preparation of a hydrate of an antranilic acid derivative
10/06/2005US20050222194 3-[p-(phenoxy, phenylthio, phenylsulfinyl, or phenylsulfonyl)benzyl]-quinolin-2(1H)-ones or 5--[p-(phenoxy, phenylthio, phenylsulfinyl, or phenylsulfonyl)benzyl]-pyrrolo[3,2,1-IJ]quinolin-4(4H)-ones; type E antagonists; analgesics, antipyretics, antiinflammatory agents; side effect reduction
10/06/2005US20050222189 Oxa-and thiadiazoles and their use as metalloproteinase inhibitors
10/06/2005US20050222187 A quaternary ammonium salts of 1-{2-(3'-chlorobiphenyl-4-yl)-2-oxoethyl}-4-(3-trifluoromethyl-phenyl)-1,2,3,6-tetrahydropyridine for treating neurodegenerative disorders; chemical synthesis; mixture with other active ingredients; Alzheimer's disease, cerebral edema, brain and nervous system disorders
10/06/2005US20050222181 Compounds in the treatment of dementia related diseases, alzheimer's disease and conditions associated with glycogen synthase kinase-3
10/06/2005US20050222179 Adenosine receptor antagonists and methods of making and using the same
10/06/2005US20050222174 N-{4-[1-(2,6-difluorobenzyl)-3-(4-fluorophenyl)-5-({methy[2-(2-oxo-1-piperidinyl)ethyl]amino}methyl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl]phenyl}-N'-ethylurea; antagonistic action for gonadotropin-releasing hormone
10/06/2005US20050222172 Active ingredient in treating neurodegenerative disease, Alzheimer's disease caused by abnormal enzyme activity
10/06/2005US20050222170 In combination with organic nitrate or nitric oxide donors or inhibitors of cyclic GMP metabolism; erectile dysfunction or female sexual dysfunction
10/06/2005US20050222160 1-[3-(3-cyclopentyloxy-4-methoxyphenyl)-3,4,5,6-tetrahydropyridazin-1-yl]-1-[4-methyl-2-(1-oxypyridin-2-yl)thiazol-5-yl]methanone, used for inhibiting proliferation of lymphocytes in a host, and for the treatment of osteoporosis, tumors, cachexia, atherosclerosis, arthritis, multiple sclerosis, diabetes
10/06/2005US20050222155 Inhibitors of akt activity
10/06/2005US20050222152 Enzyme inhibitors for disease treatment with Cathepsin s
10/06/2005US20050222137 Combination of organic compounds
10/06/2005US20050222125 For therapy of depression, anxiety and body weight disorders
10/06/2005US20050222124 Benzenesulfonamide derivatives as antipsychotic agents
10/06/2005US20050222118 For therapy of inflammatory or allergic condition
10/06/2005US20050222116 Porphyrin oxygen infusion preparation for increasing oxygen concentration in tumor tissue
10/06/2005US20050222112 Treating psychological dependency (not physical dependancy leading towithdrawal) by administering the agonist (cortisone acetate) and the addictive drug after detoxification of the dependent-patient; highly-dosed and "imprinted"by the mixture eliminates and replaces the "addiction memory"
10/06/2005US20050222099 Pregnane steroids for use in the treatment of cns disorders
10/06/2005US20050222092 Use of s1p receptor agonists in heart diseases
10/06/2005US20050222091 Use of tyrosine kinase inhibitors for treating cns disorders
10/06/2005US20050222087 Hedgehog antagonists that inhibit the hedgehog pathway in a smoothened gain-of-function cell with an IC50 within a factor of 20, 10, or even a factor of 5, of the IC50 with which they inhibit the hedgehog pathway in a patched-null cell
10/06/2005US20050222077 Administering to a subject before the onset of an ischemic episode at daily dosages of 1-2 g of free CDP-choline (CITICOLINE)
10/06/2005US20050222076 Composition for cell proliferation
10/06/2005US20050222065 Vascular therapeutics
10/06/2005US20050222062 Decoy for treating and/or preventing th2 cytokine-associated allergic disease, gata3 mutant protein and medicinal compositions containing the same
10/06/2005US20050222061 Means and methods for the specific inhibition of genes in cells and tissue of the cns and/or eye
1 ... 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 ... 1564